Insmed Inc (NAS:INSM)
$ 69.3 1.21 (1.78%) Market Cap: 12.40 Bil Enterprise Value: 11.80 Bil PE Ratio: 0 PB Ratio: 25.67 GF Score: 63/100

Insmed Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript

Jun 09, 2021 / 06:10PM GMT
Release Date Price: $27.58 (+2.41%)
Graig Suvannavejh
Goldman Sachs Group, Inc., Research Division - Executive Director & Senior Equity Research Analyst

Okay. Good afternoon, everyone, and welcome to the 2:10 session on day 2 of the Goldman Sachs Global Healthcare Conference. My name is Graig Suvannavejh. I cover U.S. and U.S. -- European, excuse me, biopharma names here at the firm. It's my great pleasure to be hosting Insmed today on a fireside chat or in a fireside chat. And with that, let me welcome the company's CEO, Will Lewis. Will, it's great to see you again, and thanks for joining us.

William H. Lewis
Insmed Incorporated - President, CEO & Chairman

Thanks for having me, Graig. Really appreciate it.

Questions & Answers

Graig Suvannavejh
Goldman Sachs Group, Inc., Research Division - Executive Director & Senior Equity Research Analyst

Okay. Great. Maybe just to -- from a high-level perspective, let's why don't we start pretty simply and this could be a situation where it's new for investors in terms of getting to know

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot